Christopher A. Boerner

2014

In 2014, Christopher A. Boerner earned a total compensation of $2.4M as Former EVP, Commercial at Seattle Genetics, a 35% increase compared to previous year.

Compensation breakdown

Option Awards$747,598
Salary$408,133
Stock Awards$1,228,140
Other$9,087
Total$2,392,958

Boerner received $1.2M in stock awards, accounting for 51% of the total pay in 2014.

Boerner also received $747.6K in option awards, $408.1K in salary and $9.1K in other compensation.

Rankings

In 2014, Christopher A. Boerner's compensation ranked 3,826th out of 13,032 executives tracked by ExecPay. In other words, Boerner earned more than 70.6% of executives.

ClassificationRankingPercentile
All
3,826
out of 13,032
71st
Division
Manufacturing
1,350
out of 4,966
73rd
Major group
Chemicals And Allied Products
436
out of 1,686
74th
Industry group
Drugs
338
out of 1,365
75th
Industry
Biological Products, Except Diagnostic Substances
54
out of 236
77th
Source: SEC filing on April 6, 2015.

Boerner's colleagues

We found five more compensation records of executives who worked with Christopher A. Boerner at Seattle Genetics in 2014.

2014

Clay Siegall

Seattle Genetics

Chief Executive Officer

2014

Jonathan Drachman

Seattle Genetics

Chief Medical Officer

2014

Eric Dobmeier

Seattle Genetics

Chief Operating Officer

2014

Todd Simpson

Seattle Genetics

Chief Financial Officer

2014

Vaughn Himes

Seattle Genetics

Chief Technical Officer

You may also like